Structural Basis for Chaperone-Independent Ubiquitination of Tau Protein by Its E3 Ligase CHIP

Angew Chem Int Ed Engl. 2022 Apr 4;61(15):e202112374. doi: 10.1002/anie.202112374. Epub 2022 Feb 18.

Abstract

The multi-site ubiquitination of Tau protein found in Alzheimer's disease filaments hints at the failed attempt of neurons to remove early toxic species. The ubiquitin-dependent degradation of Tau is regulated in vivo by the E3 ligase CHIP, a quality controller of the cell proteome dedicated to target misfolded proteins for degradation. In our study, by using site-resolved NMR, biochemical and computational methods, we elucidate the structural determinants underlying the molecular recognition between the ligase and its intrinsically disordered substrate. We reveal a multi-domain dynamic interaction that explains how CHIP can direct ubiquitination of Tau at multiple sites even in the absence of chaperones, including its typical partner Hsp70/Hsc70. Our findings thus provide mechanistic insight into the chaperone-independent engagement of a disordered protein by its E3 ligase.

Keywords: Alzheimer's Disease; CHIP E3 Ligase; NMR; Tau Protein; Ubiquitination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Molecular Chaperones / metabolism
  • Ubiquitin / chemistry
  • Ubiquitin-Protein Ligases* / metabolism
  • Ubiquitination
  • tau Proteins* / metabolism

Substances

  • Molecular Chaperones
  • Ubiquitin
  • tau Proteins
  • Ubiquitin-Protein Ligases